Emergency:

Helpline:

AMH Test Explained: What It Reveals About Ovarian Reserve

By Dr. Gayatri Deshpande in Gynaecology & Obstetrics

Apr 14 , 2026 | 5 min read

Fertility is closely linked to a woman’s ovarian health, which naturally changes over time. While age is often considered the primary factor affecting fertility, it does not always reflect the actual number of eggs remaining in the ovaries. This is where the AMH Test plays an important role. By offering insight into ovarian reserve, the test helps women gain a clearer understanding of their reproductive health. Whether someone is planning a pregnancy, considering fertility preservation, or undergoing fertility treatment, knowing ovarian reserve can support timely and better decisions.  

The AMH Test provides useful clinical information that supports personalised discussions between patients and doctors.

What Is The AMH Test And Why Is It Important? 

The AMH Test, or Anti-Mullerian Hormone Test, measures the level of Anti-Mullerian Hormone in a woman’s blood. This hormone is produced by granulosa cells in small ovarian follicles that contain immature eggs. Since these follicles represent the remaining egg supply, AMH levels are used as an indicator of ovarian reserve.

Ovarian reserve declines gradually with age, often without noticeable symptoms. The AMH Test helps identify changes in egg quantity earlier than age alone can indicate. This makes the test particularly valuable for women who wish to understand their fertility potential, plan pregnancy at a later stage, or explore fertility preservation options. Another advantage of the AMH Test is that it can be performed on any day of the menstrual cycle, offering flexibility and consistency in assessment.

Read More about the NIPT Test

What Does The AMH Test Measure In The Body?

The AMH Test focuses on the biological role of Anti-Mullerian Hormone and its relationship with ovarian function.

  • Anti-Mullerian Hormone is produced by small developing follicles in the ovaries.
  • These follicles contain immature eggs, making AMH a direct marker of egg quantity.
  • AMH helps regulate follicle development and controls how many eggs mature during each menstrual cycle.
  • Higher AMH levels generally indicate a larger pool of remaining eggs.
  • Lower AMH levels suggest reduced ovarian reserve.
  • Unlike hormones such as follicle-stimulating hormone (FSH), AMH levels remain relatively stable throughout the menstrual cycle.

Because of this stability, the AMH Test is considered a reliable indicator of ovarian reserve, although it does not assess egg quality or predict pregnancy outcomes.

What The AMH Test Reveals About Ovarian Reserve?

The primary clinical value of the AMH Test lies in its ability to estimate ovarian reserve. 

  • Low AMH levels may indicate diminished ovarian reserve, meaning fewer eggs remain in the ovaries. This can suggest a shorter reproductive window, but pregnancy may still be possible naturally or with medical support.
  • High AMH levels may be associated with conditions such as polycystic ovary syndrome (PCOS), where the ovaries contain a higher number of follicles, but ovulation may be irregular.

AMH results should always be interpreted alongside age, medical history, ultrasound findings, and other hormone tests. On their own, AMH levels do not define fertility or predict pregnancy success. 

Who Should Consider An AMH Test? 

An AMH Test may be recommended in a variety of clinical and personal situations, including:

  • Women planning pregnancy, particularly at a later reproductive age.
  • Individuals experiencing irregular menstrual cycles.
  • Women facing difficulty conceiving without an identified cause.
  • Those considering fertility preservation options, such as egg freezing.
  • Patients preparing for fertility treatments, including IVF.
  • Women are seeking a clearer understanding of their reproductive health.

The decision to undergo AMH testing should be guided by medical advice and individual reproductive goals.

Know More about Pregnancy Test: Types, Timing & How Accurate Are They?

How Is The AMH Test Performed?

The AMH Test follows a simple and standardised process that helps doctors assess ovarian reserve with reliable clinical accuracy.

  • A small blood sample is taken from a vein in the arm during a routine outpatient visit.
  • The sample is analysed in a laboratory to measure the level of Anti-Mullerian Hormone in the blood.
  • The test can be performed on any day of the menstrual cycle.
  • No fasting or special preparation is required.
  • Patients should inform their doctor about hormonal medications or previous ovarian surgery, as these factors may influence results.

The procedure is safe, minimally invasive, and generally well tolerated.

Different AMH Test Results

AMH levels are interpreted using age-related reference ranges rather than a single universal value.

  • Normal AMH levels suggest ovarian reserve appropriate for a woman’s age.
  • Low AMH levels indicate reduced egg quantity and may influence fertility planning decisions.
  • High AMH levels may suggest hormonal imbalance or conditions such as PCOS.

Since AMH levels do not predict natural conception or egg quality, it is essential to consult a fertility specialist to understand the clinical relevance of the results.

Limitations Of The AMH Test 

Although the AMH Test is a valuable fertility marker, it has important limitations. 

  • It does not assess egg quality.
  • It cannot predict the likelihood of a natural pregnancy.
  • Results may be influenced by medical conditions, medications, or prior ovarian surgery.
  • AMH levels alone should not be used to diagnose infertility.

For a comprehensive fertility evaluation, AMH results are best combined with ultrasound findings and other hormonal assessments.

AMH Test In Fertility Treatment Planning 

The AMH Test plays an important role in fertility treatment planning and long-term reproductive decision-making. Measuring Anti-Mullerian Hormone (AMH) levels allows doctors at Nanavati Max Super Speciality Hospital to assess how a woman’s ovaries may respond to stimulation during treatments such as IVF. This enables personalised treatment protocols, optimising outcomes and minimising the risk of complications.

Beyond assisted reproduction, AMH results support better discussions about fertility preservation and future family planning. When combined with other clinical assessments, the AMH Test helps women make confident, better decisions about their reproductive health under expert medical guidance.

Learn More about Women's Health Check-Ups: Importance & Checkup List

Disclaimer: The information provided in this article is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. AMH levels are only one piece of the fertility puzzle. Always seek the advice of your physician or a qualified fertility specialist with any questions you may have regarding a medical condition. 

Frequently Asked Questions 

1. Is the AMH Test painful?

The test involves a routine blood draw and causes minimal discomfort.

2. Can AMH Test levels change over time?

Yes. AMH levels naturally decline with age, although they may remain stable for shorter periods.

3. How often should the AMH Test be done?

Testing frequency depends on age, fertility goals, and medical guidance.

4. Does a low AMH Test mean infertility?

No. Low AMH reflects reduced egg quantity but does not rule out pregnancy, either naturally or with treatment.

5. What is the AMH level to get pregnant?

A normal AMH (Anti-Mullerian Hormone) level for pregnancy is generally considered to be between 1.0 ng/mL and 3.0–4.0 ng/mL, indicating a good ovarian reserve. While levels above 4.0 ng/mL may indicate PCOS, levels below 1.0 ng/mL suggest a low egg count, potentially making natural conception harder.

6. When is the best time to take the AMH test?

The best time to take an Anti-Müllerian Hormone (AMH) test is any day of the menstrual cycle. Because AMH levels are stable and do not fluctuate significantly throughout the cycle, unlike follicle-stimulating hormone (FSH)

References 

Journal of Assisted Reproduction and Genetics, 32(10), 1441-1448.
https://doi.org/10.1007/s10815-015-0562-7